Media Alert; NXT-ID Chief Technology Officer Comments on Why You Need a Smart Wallet

SHELTON, Conn., Oct. 27, 2014 /PRNewswire/ -- NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or the "Company"), a biometric authentication company focused on the growing mobile commerce market issues a recent blog entry from Mr. David Tunnell, Chief Technology Officer. Mr Tunnell examines the case for a smart wallet like Wocket™.

With the variety of new payment solutions being released, consumers may ask which method is best? Each new payment method has its own attributes that promise to make payments more convenient and secure. The good news is that none of these new payment methods are mutually exclusive to one another. Each has its own merit depending on where it can be used. For instance, digital wallets such as Google Wallet, Apple Pay or SoftCard (formally ISIS) may be preferable for locations that accept NFC (Near Field Communications), while another solution might be a better choice for locations that require a new barcode payment system such as being developed by major retailers like Wal-Mart, Target and Best Buy. Since none of the new payment methods can be used universally at all locations, the question remains – do you still need a wallet?

Most digital wallets have one thing in common: They all are dependent upon a cell phone. Each new payment method added to a cell phone can be advantageous, depending on when and where you wish to make a payment, but there are always instances where a cell-phone based payment method may not be practical.  A cell phone based payment solution may not be practical when:

Getting money from an ATM. Making a purchase at one of the millions of retail outlets that have not yet replaced their existing point of sale (POS) terminals with new upgraded ones. Making payments in areas with poor connectivity to the Internet. There is a risk that your cell phone battery might run out. Bluetooth does not pair, which may occur with certain methods that require Bluetooth connection with the phone. Then, there is the issue of cash. There are still instances you may need cash or other private information that you want to secure but can't afford to leave at home. These are just some examples of when you may wish you had your wallet with you. 

Smart wallets add electronics to wallets and purses so that you keep your private information secure, only accessible by you. Smart wallets also securely store all of your personal information, not just payment accounts. Furthermore, smart wallets are agnostic to the payment method, capable of supporting new payment methods as they emerge.

So, no matter whether you choose one or more new payment methods associated with your cell phone, there will always be a reason you wished you had a smart wallet. 

We encourage you to take a look at the features of the Wocket™ Smart Wallet and how it might benefit not only your shopping experience, but also all aspects of your wallet by giving you peace of mind with added security to all your personal information.

About NXT- ID Inc. - Mobile Security for a Mobile World: (NXTD) (NXTDW):

NXT-ID, Inc.'s innovative MobileBio® solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio® suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com

NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification that has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com, http://3d-id.net.

Forward-Looking Statements for NXT-ID:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact:

Corporate info: info@nxt-id.com
Investor Inquiries: Kirin Smith
ProActive Capital Group
Direct: +1-646-863-6519
ksmith@proactivecapital.com
Media: 800-665-0411
dvanzant@investorideas.com

SOURCE NXT-ID, Inc.

RELATED LINKS
http://www.wocketwallet.com
http://www.nxt-id.com

reade more... Résuméabuiyad

MedNet Appoints Clareece West As Chief Operating Officer

MINNETONKA, Minn., July 23, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that M. Clareece West, a proven life sciences industry executive with over 25 years of experience, has been named Chief Operating Officer (COO).  Clareece will be responsible for MedNet's day-to-day operating activities, driving revenue and sales growth, operational efficiency and quality product/service delivery. 

"We welcome Clareece, who brings an exceptional track record in operations, executive management and global business development," noted John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "With Arrowroot Capital's recent investment in our company, and the very positive reception that iMedNet™ EDC is receiving from both the sponsor and CRO communities, she is joining MedNet at an incredibly exciting time.  The future is very bright for our company, and I'm thrilled to have Clareece join our executive team as we work to take MedNet to the next level."

"MedNet's growth strategy and quality eClinical technology platforms combined with their impeccable industry reputation make this an exciting opportunity," remarked Clareece West.  "Their established footprint within the device and pharma communities, along with their continued focus on serving the technology needs of both CROs and sponsors, align perfectly with our industry's craving for better and more efficient technologies to help offset expensive service costs."

Prior to joining MedNet, Clareece held senior leadership positions with global Clinical Research Organizations (CROs).  Clareece brings significant M&A experience and extensive international business expertise that will be valuable for MedNet's continued global expansion. 

Stay in touch with MedNet:

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data solutions designed for the global life sciences community.  MedNet's proven, flexible and easy-to-use cloud-based eClinical systems dramatically improve the efficiency of clinical studies and registries of all types and sizes.  Beyond simply electronic data capture (EDC), MedNet's solutions deliver the tools and dashboards required to expertly manage all aspects of clinical research.  Since 2001, pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have trusted MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

Contact Information:
Dirk H. Nelson
Director of Marketing
110 Cheshire Lane, Suite 300
Minnetonka, MN 55305
USA
(763) 258-2735

SOURCE MedNet Solutions

RELATED LINKS
http://www.mednetstudy.com

reade more... Résuméabuiyad

Medbox Chief Executive Officer to Appear on Bloomberg TV's "In the Loop with Betty Liu" on May 20, 2014

LOS ANGELES, May 20, 2014 /PRNewswire-USNewswire/ -- Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), a leader in providing ancillary services to the alternative medicine industry, dispensary consulting services, and patented medicine dispensing systems to medical and retail industries, today announced that Dr. Bruce Bedrick, chief executive officer of Medbox, will appear on Bloomberg TV's "In the Loop with Betty Liu" on May 20, 2014 at 9:35 am ET. 

Dr. Bedrick has been invited to appear to discuss Medbox and its dispensing and storage systems, along with recent headlines regarding the legalized business of marijuana. Medbox is the industry leader in the legal marijuana industry. The Company has consulted with more than 400 clients in six states, helping businesses secure licenses, identify locations, build-out dispensaries, educate patients and conduct business in a safe, secure, and legally compliant way. 

About Betty Liu:

Betty Liu is editor-at-large for Bloomberg Television and the host of "In the Loop with Betty Liu," a weekday program providing the fastest and most comprehensive coverage of the headlines and major events set to shape the business day ahead. She also hosts "In the Loop, At the Half" on Bloomberg Radio, airing weekdays at noon. An award-winning business journalist, Liu regularly interviews influential business, political and media leaders including Warren Buffett, Carlos Slim, Ted Turner and Lloyd Blankfein. Before joining Bloomberg Television, Liu served as an anchor for CNBC Asia based in Hong Kong. Prior to that, she was the Atlanta bureau chief for the Financial Times. Earlier in her career, Liu was the Taiwan bureau chief for Dow Jones Newswires - the youngest ever in Asia - and a Hong Kong-based regional correspondent for the newswire. In 1997, she received a Dow Jones Newswires Award for her coverage of the Asian financial crisis.

About Medbox, Inc.:? 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws.? Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control.? In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.? Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation.? We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Medbox, Inc. is a publicly traded company, and is quoted on the OTCQB, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medbox.com. 

Contacts: 

Investors 
Stephen Hart 
Hayden IR 
+1- 917-658-7878 
hart@haydenir.com 

SOURCE Medbox, Inc.

RELATED LINKS
http://www.medbox.com

reade more... Résuméabuiyad

FST21 Appoints Arie Melamed As Chief Marketing Officer

NEW YORK, March 27, 2014 /PRNewswire/ -- FST21, the leading biometric access solution provider, today announces the addition of Arie Melamed to the company's C-level staff as Chief Marketing Officer.

Mr. Melamed brings with him over 20 years of experience in sales and marketing, most recently having served as Head of Global Marketing & Channel Sales for ECI Telecom, a global telecommunication networking provider.    

"It's an honor to join FST21, a company on the cutting edge of biometric access control technology," says Mr. Melamed. "Biometric access control is a hot topic for both the national and international security markets, and I am thrilled to utilize my experience and knowledge to lead the company's marketing forward."

At ECI Telecom, Mr. Melamed managed a global marketing and channel team. His vast knowledge of sales and marketing tactics helped him lead an increase in the company's indirect sales and implement a series of progressive revenue marketing procedures.

"Arie has a proven record of change management with high-profile technology companies. I am confident that his past experience overseeing global marketing for a major telecommunications company will allow him to manage our international marketing ventures effortlessly," says Major-General Aharon Zeevi Farkash, Founder and CEO, FST21. "The team is excited to have him in the company, and we all look forward to the expansion of FST21's business over the next year." 

Previously to ECI, Mr. Melamed also spent several years as the Associate Vice President of Sales for Enavis Networks. Mr. Melamed earned a degree in Applied Physics and Electro-Optics from the Jerusalem College of Technology, as well as an MBA from Ben Gurion University in Israel.

FST21 has recently announced growth plans for the future, including its continued expansion into the U.S. market with the opening of an office at 7 World Trade Center in New York City. 

ABOUT FST21:
FST21 is a leading biometric access control solutions provider. FST21's SafeRise provides top security and convenience by fusion of real time information for fast and automatic access control. It's hassle-free and allows authorized users quick and convenient access. SafeRise's In Motion Identification™ uses a fusion of biometric and analytic technologies that include facial recognition, behavior analysis and voice recognition.

SOURCE FST21

RELATED LINKS
http://www.fst21.com

reade more... Résuméabuiyad